Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Interlaboratory assessment of alternatives to the Draize eye irritation test in GermanyH Spielmann, I Gerner, S Kalweit, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 18, 2014
Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA studyBjörn A Blomberg, Anders Thomassen, Richard A P Takx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [18F]PSMA-1007 PET/CT and [18F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient ManagementKaren M Buch-Olsen, Mie H Vilstrup, Steinbjørn Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2019
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairmentEivind A Segtnan, Alireza Majdi, Caius Constantinescu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2022
Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing 18F-FDG PET/CT with Conventional CTMarianne Vogsen, Frederik Harbo, Nick M Jakobsen, et al.
European Urology Open Science|June 8, 2026
Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET/ceCT Versus Na[18F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled TrialKaren M Buch-Olsen, Steinbjørn Hansen, Mie H Vilstrup, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2017
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor controlR J Klement, M Guckenberger, H Alheid, et al.
BMC Cancer|March 15, 2018
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastasesN Andratschke, H Alheid, M Allgäuer, et al.
Journal of Viral Hepatitis|June 3, 2009
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resourcesJ Wiegand, B Luz, A-K Mengelkamp, et al.
Pageof 31